EcoDrugPlus

Histone Deacetylase 10

Ensembl ID : ENSOSIG00000012926
Gene Symbol: HDAC10
1 Cross references
181 Possible Orthologues:

Histone Deacetylase 2

Ensembl ID : ENSOSIG00000018708
Gene Symbol: HDAC2
1 Cross references
209 Possible Orthologues:

Histone Deacetylase 3

Ensembl ID : ENSOSIG00000014811
Gene Symbol: HDAC3
1 Cross references
155 Possible Orthologues:

Histone Deacetylase 4

Ensembl ID : ENSOSIG00000009068
Gene Symbol: HDAC4
1 Cross references
202 Possible Orthologues:

Histone Deacetylase 5

Ensembl ID : ENSOSIG00000005244
Gene Symbol: HDAC5
1 Cross references
194 Possible Orthologues:

Histone Deacetylase 7

Ensembl ID : ENSOSIG00000019236
Gene Symbol: HDAC7
1 Cross references
189 Possible Orthologues:

Histone Deacetylase 8

Ensembl ID : ENSOSIG00000017058
Gene Symbol: HDAC8
1 Cross references
205 Possible Orthologues:

Hyperpolarization Activated Cyclic Nucleotide Gated Potassium Channel 4

Ensembl ID : ENSOSIG00000005947
Gene Symbol: HCN4
1 Cross references
221 Possible Orthologues:

Hyperpolarization Activated Cyclic Nucleotide Gated Potassium Channel 4

Ensembl ID : ENSOSIG00000000723
Gene Symbol: HCN4
1 Cross references
212 Possible Orthologues:

Hypocretin (Orexin) Receptor 2

Ensembl ID : ENSOSIG00000010323
Gene Symbol: HCRTR2
1 Cross references
203 Possible Orthologues:

Inhibitor Of Nuclear Factor Kappa B Kinase Subunit Beta

Ensembl ID : ENSOSIG00000015909
Gene Symbol: IKBKB
1 Cross references
199 Possible Orthologues:

Insulin Receptor A

Ensembl ID : ENSOSIG00000019905
Gene Symbol: INSRA
1 Cross references
213 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).